top of page
Dark-Background

2024-2026

IMRIC Center for Addiction Research

 New psychedelic entities as a potential treatment for drug addiction 

ICARe

IMRIC Center for Addiction Research

ICARe grant

dimatsv_4k_cinematic_logo_for_website_of
image_edited.jpg
Dark-Background

2024-2025

Ministry of Innovation - Yissum 

Science Accelerator grant

Revolutionizing Drug Design:

Harnessing Compact 3D Molecular Cages for Targeted Therapeutics

channels4_profile.jpg

משרד החדשנות, המדע והטכנולוגיה

Ministry of Innovation, Science and Technology

Dark-Background

2023-2025

Ministry of Innovation

Nofar grant

Novel Psychedelic Drugs for the Treatment of Psychiatric Disorders

תכנית הכוונת ידע אקדמי במסלול שלבים מוקדמים

%D7%A8%D7%A9%D7%95%D7%AA%20%D7%9C%D7%97%D7%93%D7%A9%D7%A0%D7%95%D7%AA_edited.png

רשות החדשנות

Israel Innovation Authority

Image by CDC
Dark-Background

2023-2025

Ministry of Innovation - Yissum 

Science Accelerator grant

Synthesis of novel confluent antibacterial compounds by molecular hybridization of natural antibiotic core elements

channels4_profile.jpg

משרד החדשנות, המדע והטכנולוגיה

Ministry of Innovation, Science and Technology

Image by julien Tromeur
Dark-Background

2022-2024

Israel Innovation Authority

Bio-convergence grant

Developing novel cannabinoid-based analgesics: targeting the pain receptors TRPV1 and TRPA1

%D7%A8%D7%A9%D7%95%D7%AA%20%D7%9C%D7%97%D7%93%D7%A9%D7%A0%D7%95%D7%AA_edited.png

רשות החדשנות

Israel Innovation Authority

Dark-Background

2021-2022

Israel Innovation Authority

Bio-convergence grant

Development of a Novel Neurotropic Drug for Polyneuropathy

%D7%A8%D7%A9%D7%95%D7%AA%20%D7%9C%D7%97%D7%93%D7%A9%D7%A0%D7%95%D7%AA_edited.png

רשות החדשנות

Israel Innovation Authority

Dark-Background

2021-2022

Contract signed with Clearmind Medicine Inc

Psychedelic drug development company Clearmind Medicine Inc. will fund a study for the development of novel psychedelic drugs ( about Clearmind)

Screen Shot 2021-07-22 at 9.33_edited.jpg

Clearmind Medicine Inc

Psychedelic Drug Company

1200px-Yahoo_Finance_Logo_2019_edited.pn
600.png
dimatsv_cannabis_realm_edited.jpg
Dark-Background

2019-2020

Contract signed with

Scopus Bopharma

The Scopus Biopharma company will fund the conduct of a feasibility study for the development of protocols for the synthesis of new CBD derivatives

Multidisciplinary Center for Cannabinoid Research

1_new_edited_edited_edited.png
Dark-Background

2018-2023

Israel Science Foundation

ISF research grant

The research funds were awarded for the period of 2018-2022. Project: Stretching the Model of TRPV1 Activation

download-1.png

Israel Science Foundation ISF

Dark-Background

2017-2018

Ministry of Science and Industry 

Nofar grant

Novel Synthetic Scaffold DT100 Promotes Silencing of the Pain Receptor TRPV1

ITC-Logo-Sydney-Australia-with-MoE_edited.jpg

Ministry of Economy and Industry

Dark-Background

2014-2018

Volkswagen Stiftung

grant

Structure Pattern Recognition: A Catalyst for Methodology Development in Total Synthesis. Cooperation Lower Saxony - Israel

VolkswagenFoundation.jpg

Volkswagen Foundation

Image by Chromatograph
Dark-Background

2012-2016

Marie Skłodowska-Curie  

Integration grant

Concise Synthesis of Tricyclic Angularly Fused Natural Products via Controlled Cyclizations of a Common Key Precursor

MARIECURIE.jpg

Marie Skłodowska-Curie Actions

Image by Chromatograph
Dark-Background

2013-2014

German-Israel Foundation  

 Young Scientists' program grant

Pd-Catalyzed Cascade Cyclization-Epoxidation Approach to the Total Synthesis of Oxaspirofuranones

GIF logo.jpg

German-Israel Foundation

bottom of page